Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: A Single-Institution Experience and a Review of the Literature

Publisher： Karger

E-ISSN： 1423-0232|91|4|211-216

ISSN： 0030-2414

Source： Oncology, Vol.91, Iss.4, 2016-08, pp. : 211-216

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chemotherapy with Gemcitabine and Oxaliplatin in Patients with Advanced Biliary Tract Cancer: A Single-Institution Experience

By  

Oncology, Vol. 73, Iss. 5-6, 2008-05 ,pp. : 311-315

Karger

Access to resources Recommend Favorite

Surgical Resection of Isolated Adrenal Metastases in Patients with Non-Small Cell Lung Cancer: A Single-Institution Experience and Review of the Literature

By  

Oncology Research and Treatment, Vol. 34, Iss. 12, 2011-11 ,pp. : 665-670

Karger

Access to resources Recommend Favorite

The Role of Neoadjuvant Chemotherapy in the Treatment of Advanced Ovarian Cancer

By  

Oncology, Vol. 68, Iss. 1, 2005-04 ,pp. : 64-70

Karger

Access to resources Recommend Favorite

Solid tumor metastases to the pancreas diagnosed by FNA: A single‐institution experience and review of the literature

By  

CANCER CYTOPATHOLOGY, Vol. 123, Iss. 6, 2015-06 ,pp. : 347-355

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oncologic Concerns regarding Laparoscopic Cytoreductive Surgery in Patients with Advanced Ovarian Cancer Submitted to Neoadjuvant Chemotherapy

By  

Oncology, Vol. 89, Iss. 3, 2015-05 ,pp. : 159-166

Karger

Access to resources Recommend Favorite